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Summary
 
This paper describes an antibody (mAb 7D6) that specifically recognizes human follicular den-
dritic cells (FDCs). By expression cloning, a cDNA clone encoding for the long human CR2/
CD21 isoform (CD21L) that contains an additional exon (10a) was isolated. We demonstrated
that FDCs selectively express CD21L, while B cells selectively express the short CR2/CD21
lacking exon 10a (CD21S). By screening mouse Ltk
 
2
 
 cells transfected with the CD21L cDNA,
we further showed that the other two anti–human FDC mAbs DRC-1 and KiM4 also recog-
nize CD21L. Thus, CD21L represents the first characterized human FDC-specific molecule,
which may confer unique functions of FDCs in germinal center development.
 
S
 
econdary lymphoid organs such as lymph nodes, spleen,
Peyer’s patches, and tonsils represent the major sites
where immune responses to antigens occur. These lym-
phoid organs are divided into a T cell compartment (T cell
zone or extrafollicular area) and a B cell compartment (B
lymphoid follicle). While T cell zones contain interdigitat-
ing dendritic cells that play key roles in presenting antigen
to naive T cells (1), B cell follicles contain follicular den-
dritic cells (FDC) that have the capacity to retain native an-
tigen–antibody immune complexes for long periods of time
(2, 3). During T cell–dependent humoral (antibody) immune
responses, antigen-specific B cells undergo rapid clonal ex-
pansion within the FDC networks of B cell follicles, lead-
ing to the formation of germinal centers (GC) (4). During
the course of clonal expansion, somatic hypermutation in
immunoglobulin variable region genes (5, 6), and isotype
switch in immunoglobulin constant region genes occur (7).
After antigen-driven affinity selection (8), high affinity ger-
minal center B cells will differentiate into either plasma cells
or memory B cells (9–11). The functions of FDC in the
GC reaction were proposed because of their selective local-
ization and their ability to retain immune complexes. Both
in vivo and in vitro experiments have suggested that FDC
play important roles in GC B cell proliferation, survival,
and differentiation (12–15). However, little is known at the
molecular level of how FDCs contribute to GC develop-
ment. Several monoclonal antibodies have been generated
against FDCs (16, 17); however, the nature and function of
the antigens recognized by these monoclonal antibodies are
unknown. Here, we describe an antibody (mAb 7D6) that
specifically recognizes human FDC. By expression cloning,
using mAb 7D6, a cDNA clone encoding for the long iso-
form of CD21L (CD21L) that contains an additional exon
(10a) was isolated. We show that FDC selectively express
CD21L, while B cells selectively express the short CD21
(CD21S) lacking exon 10a. By screening mouse L cells
transfected with the CD21L cDNA, we further demon-
strate that the other two anti–human FDC mAbs, DRC-1
and KiM4, also recognize CD21.
 
Materials and Methods
 
Isolation of FDC from Human Tonsils by Percoll Gradient.
 
Ton-
sils obtained from children undergoing tonsillectomy were cut into
small pieces and digested for 12 min at 37
 
8
 
C with an enzyme
cocktail in RPMI 1640 medium (GIBCO BRL, Gaithersburg,
MD) containing collagenase IV (1 mg/ml; Sigma Chemical Co.,
St. Louis, MO) and deoxyribonuclease I (50 kU/ml; Sigma
Chemical Co.). The released cells were collected and a new stock
of enzyme solution was added to the remaining tissue fragments
for another 12 min. The cells, collected after two successive
rounds of enzymatic digestion, were pooled and centrifuged
through Ficoll-Hypaque (Eurobio, Paris, France) for 20 min at
400 
 
g
 
 to remove red and dead cells. After two washes, cells were
layered on a 1.5% BSA (Pentex
 
Ò
 
 Path-o-cyte 5; Miles Inc.,
Kankakee, IL) gradient and centrifuged at 10 
 
g
 
 for 10 min at 4
 
8
 
C.
The FDC-lymphocyte clusters were recovered from the pellet.
This BSA gradient process was repeated two to three times. The
resulting cell population contains 15–30% FDC that form tight
clusters with lymphocytes (13).
 
Isolation of a Highly Purified Single FDC Suspension by FACS
 
Ò
 
Sorting of CD14
 
1
 
CD21
 
1
 
 Large Tonsillar Cells.
 
Since human B
cells, T cells, fibroblasts, endothelial cells, and epithelial cells ex-
press no or low levels of CD14, and human T cells, fibroblasts,
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endothelial cells, and epithelial cells express no or low levels of
CD21, CD14
 
high
 
CD21
 
high
 
 FDC were isolated by FACS
 
Ò
 
 sorting
of enriched FDC preparations by Percoll gradient. After cell sort-
ing, the resulting population contained 
 
.
 
98% pure single FDC
(Fig. 3). These highly purified FDCs may have been damaged in-
asmuch as they displayed cytoplasm losses and were unable to
support B cell growth in vitro. However, these cells were used
for PCR assays.
 
Purification of Tonsillar B Cells, Follicular Mantle B Cells, and GC
B Cells.
 
Briefly, tonsils were finely minced and the resulting cell
suspension was subjected to two rounds of T cell depletion using
first rosetting with sheep red blood cells, and then depletion
with anti-CD3 magnetic beads. The resulting purified cells con-
tained 
 
.
 
97% CD19
 
1
 
 B cells and 
 
,
 
1% T cells and monocytes. To
isolate IgD
 
1
 
CD38
 
2
 
 follicular mantle B cells and IgD
 
2
 
CD38
 
1
 
germinal center B cells, total tonsillar B cells (10
 
7
 
/ml) were incu-
bated with anti–IgD-FITC and anti–CD38-PE in PBS con-
taining 2% BSA (PBS–BSA) for 30 min. Cells were washed twice
and suspended in PBS at 3 
 
3
 
 10
 
6
 
/ml. The two B cell subpopula-
tions were then purified by cell sorting. Two rounds of cell sort-
ing were carried out to obtain 
 
.
 
98% purity.
 
Generating FDC-specific mAb 7D6.
 
BALB/c mice were im-
munized with 5 
 
3
 
 10
 
6
 
 enriched human tonsillar FDC intraperi-
toneally three times at 3-wk intervals. The final boost was carried
out 3 d before fusion. Using polyethylene glycol 1500 (Boehrin-
ger Mannheim GmbH, Mannheim, Germany), 50 
 
3
 
 10
 
6
 
 splenic
cells were fused with NS1 myeloma cells. Hybridomas were cul-
tured in complete medium supplemented with 20% vol/vol FCS,
hypoxanthine and azaserine, oxaloacetic acid, pyruvate, and insu-
lin (OPI; Sigma Chemical Co.). Hybridomas were selected by
immunohistological staining of the culture supernatants of the
FDC networks on tonsillar tissue sections. Ascites was produced
in BALB/c mice, and mAb 7D6 (IgG1) was purified by high-
pressure liquid chromatography with an anion-exchange column
(DEAE 5PW; Waters Chromatography Div., Milford, MA).
 
Immunoenzymatic Staining.
 
Frozen sections from human ton-
sils, spleen, and thymus were washed in PBS for 5 min. The sec-
tions were incubated with mouse IgG1 mAb 7D6, anti-CD21,
and anti-CD54, respectively, for 60 min. After washing for 5 min
in PBS, the sections were incubated with sheep anti–mouse IgG1
for 30 min in PBS containing 10% human serum, and then with
alkaline phosphatase coupled to mouse antibodies specific for al-
kaline phosphatase (APAAP complexes; Dako, Roskilde, Den-
mark). After a final washing, alkaline phosphatase was developed
by Fast red substrate (Sigma Chemical Co.) which gives a red
color. Cytospin preparations of FDC clusters were fixed in ace-
tone for 10 min at 4
 
8
 
C. The slides were washed in PBS and incu-
bated for 1 h with the anti-FDC mAb 7D6. After washing, the
cytospin slides were incubated for 30 min with anti–mouse IgG1.
The binding of antibody was revealed using APAAP method and
developed by Fast red substrate.
 
cDNA Library Construction and Screening.
 
Poly(A)
 
1
 
 RNA was
purified from a B lymphoblastic cell line IM9 established from a
bone marrow sample of a myeloma patient. This cell line stained
weakly (variable; 
 
>
 
28% positive cells) with mAb 7D6. cDNA
library construction was as described (18) using the Superscript Re-
verse Transcriptase cDNA Synthesis Kit (GIBCO BRL). Double-
stranded cDNA was size-fractionated using a Chromaspin-1000
column (Clontech, Palo Alto, CA) and ligated into the BstxI/
NotI-digested pJFE14 expression vector (19).
A cDNA clone encoding the 7D6 antigen was isolated by a
method similar to that described (18) except that cell sorting
(FACS
 
Ò
 
), rather than panning, was used to enrich COS7 cells
transiently expressing the 7D6 antigen (20). After a 1 h incuba-
tion with 50 
 
m
 
g/ml isotype IgG1 antibody to block binding to
Fc
 
g
 
R, COS7 cells were stained with 10 
 
m
 
g/ml biotinylated mAb
7D6. Cells which bound mAb 7D6 were detected with streptavi-
din–phycoerythrin (Becton Dickinson, Milpitas, CA). Plasmid
DNA recovered from sorted cells was transformed into 
 
Escherichia
coli
 
 DH10B for expansion and then reintroduced into COS7
cells. A cDNA clone (p7D6) with a 4 kb insert was identified
which encoded the antigen recognized by mAb 7D6. The se-
quence of the cDNA insert was determined in part manually as
described (18), and in part on an automated sequencer (Applied
Biosystems, Foster City, CA) using Taq Dye Deoxy Terminator
cycle sequencing.
 
Expression of the 7D6 Antigen.
 
The 7D6 cDNA clone was ex-
pressed transiently in COS7 cells (18). Mouse Ltk
 
2
 
 cells (L cells)
stably expressing the 7D6 antigen were generated by cotransfec-
tion with a neomycin-resistance plasmid by the calcium phos-
phate method (GIBCO BRL). Cells which survived in 1 mg/ml
G418 were selected for 7D6 expression by FACS
 
Ò
 
 and also were
positive for CD21 (CALTAG Labs., South San Francisco, CA).
 
PCR Assay to Detect the Expression of Short and Long CD21 Iso-
forms.
 
mRNA was extracted from 10
 
4
 
 FDC purified by FACS
 
Ò
 
sorting according to their high expression of CD21 and CD14
antigens. cDNA was obtained by reverse transcription (Superscript
Reverse Transcriptase Kit; GIBCO BRL). PCR assay was per-
formed using a 5
 
9
 
 primer UHCR2-1704 (GGAGAGAGCAC-
CATCCGTTG), a 3
 
9
 
 primer ULCR2-2363 (GGGCAGC-
GAGTCACAGGAGGAG) (see Fig. 2), and a taq polymerase
(Perkin-Elmer Corp., Norwalk, CT) in a thermal cycler. The
first cycle of denaturation was at 94
 
8
 
C for 3 min, and then 35 cy-
cles including 1 min of denaturation at 94
 
8
 
C, 2 min for primer
annealing at 60
 
8
 
C, and 3 min of extension at 72
 
8
 
C. Complete ex-
tension was achieved for 10 min at 72
 
8
 
C. PCR products were
loaded on a 1% low melting point gel for purification (WIZARD
PCR DNA Purification System; Promega Biotec, Madison, WI).
These products were ligated and cloned in the PCR
 
tm
 
II vector
with TA cloning kit (Invitrogen, San Diego, CA). Plasmids were
extracted from individual bacterial colonies and both strands were
sequenced on an automated DNA sequencer (Applied Biosys-
tems) using PCR II vector primers (21 M13, and M13RP).
 
Results and Discussion
 
mAb 7D6 Selectively Stains FDC.
 
mAb 7D6 was selected
because it specifically stains FDC networks on tonsillar and
splenic sections (Fig. 1, 
 
A
 
 and 
 
C
 
). The reactivity on FDC
networks was further confirmed by staining of isolated
FDCs (Fig. 1, 
 
G
 
 and 
 
H
 
). 7D6 antibody did not give any
specific staining on sections from fetal thymus (Fig. 1 
 
E
 
) or
fetal liver (not shown). There was no positive staining of
mAb 7D6 on total cell suspensions of bone marrow and
peripheral blood by FACS
 
Ò
 
 analysis (not shown).
 
7D6 cDNA Encodes the CD21L.
 
After screening over 50
cell lines including Burkitt’s lymphoma cells, B lympho-
blastoid cells, T cells, myeloma cells, monocytic cells, and
erythroblastoid cells, we found that Raji (Burkitt’s lym-
phoma cell), UD123, UD261, IM9 (lymphoblastoid B cells),
and K562 (erythroblastoid) expressed low, but significant,
levels of 7D6 antigen (7–28% of cells were positive). Ac-
cordingly, we isolated a 4-kb cDNA clone from the IM9
cDNA library by FACS
 
Ò
 
 sorting. Transfection of COS7 
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and L cells with p7D6 cDNA resulted in expression of the
7D6 antigen (not shown). The sequence of the p7D6
cDNA insert matched the sequence of long CR2/CD21
isolated from the Raji cell line (21), with several polymor-
phisms as described (22), and two additional ones: position
1979 [AGT (Ser) 
 
®
 
 A AT (Asn)] and position 2075 [CGT
(Arg) 
 
®
 
 CAT (His)] (The sequence of the 7D6-reactive
isoform of CD21 is available upon request). Consistent
with this finding, all the anti-CR2/CD21 mAbs available
from the Fifth International Leukocyte Typing Workshop
that had been shown to stain both B cells and FDCs,
stained p7D6 cDNA transfected Cos7 cells or L cells (not
shown). However, mAb 7D6 is specific for FDC, and does
not recognize CD21 expressed on other cells. Two CD21
isoforms have been described. A “long” form (CD21L) has
an extracellular domain with 16 short consensus repeats
(SCR) (Fig. 2), and is encoded by p7D6 and the clone de-
scribed earlier (23). A short CD21 isoform was reported
with an extracellular domain containing only 15 SCRs,
the missing SCR (SCR10a) of 59 amino acids being en-
coded by 177 bp (Fig. 2) (23). Whether the mAb 7D6
epitope is encoded by SCR10a, or is a conformational de-
terminant induced elsewhere in the molecule by the pres-
ence of SCR10a, is not known.
Figure 1. mAb 7D6 specifi-
cally stains FDC networks within
tonsillar and splenic GCs or
FDCs in isolated form. (A) Red
mAb 7D6 staining of FDC net-
works within a GC of human
tonsil (DZ, dark zone; LZ, light
zone;  3200). (B) Red anti-
CD21 staining of FDC networks
and B lymphocytes within the
follicular mantle (FM) and ex-
trafollicular area (A and B show
the same secondary follicle on
two serial sections). (C) mAb
7D6 staining of FDC networks
within a primary follicle of hu-
man spleen (CA, central arteri-
ole;  3200). (D) anti-CD21
staining of FDC networks as well
as follicular B cells and marginal
zone (MZ) B cells (C and D
show the same splenic white
pulp on two serial sections). (E)
Negative mAb 7D6 staining on
human thymus (3200). (F) Posi-
tive staining of anti-ICAM1/
CD54 on human thymus (E and
F show the same thymic area on
two serial sections) (C, cortex.
M, medullar). (G) Giemsa stain-
ing of isolated FDC-lymphocyte
clusters. FDC can be recognized
as cells containing one or two
big round nuclei with decon-
densed chromatin and clear nu-
cleoli (31000). (H) mAb 7D6
staining of isolated FDCs. 
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Human B Cells Selectively Express the CD21S; FDC Selec-
tively Express CD21L.
 
The pattern of mAb 7D6 staining
suggests that FDC specifically express CD21L, while B cells
specifically express CD21S. To directly test this hypothesis,
a PCR assay using a 5
 
9
 
 primer starting from basepair 1704
and a 3
 
9
 
 primer starting from basepair 2363 of the short
CR2/CD21 sequence, was carried out on RNA from 10
 
4
 
highly purified FDC (Fig. 3) in parallel with follicular man-
tle B cells (FM) and GC B cells isolated by FACS
 
Ò
 
 sorting.
Fig. 4 shows that a single large PCR product was generated
from FDC, and a single smaller PCR product was gener-
ated from both FM and from GC B cells of the same do-
nor. Further, sequencing analysis of these two PCR prod-
ucts shows that the FDC-derived large PCR product is
836 bp containing the 177-bp insertion that encodes the
SCR10a. The B cell–derived PCR product is 659 bp, which
does not contain the 177-bp insert (Fig. 5).
mAbs DRC-1 and KiM4 have been widely used as hu-
man FDC-specific antibodies, but the target antigen(s) have
not been characterized (16, 17). Interestingly, both DRC-1
and KiM4 strongly and specifically stain COS7 cells as well
as L cells transfected with CD21L cDNA (not shown). This
indicates that 7D6, DRC-1, and KiM4 specifically recog-
nize the CR2/CD21L that is selectively expressed by
FDCs. The weak staining of DRC-1 and KiM4 on tonsil-
lar B cells may be explained by the cross-reaction of these
two antibodies to CD21S expressed on B cells.
In conclusion, the present study demonstrates that FDC
express the SCR10a-containing CD21L, and this long
form of CD21 appears to be a specific cell surface marker
for FDC. In contrast, B cells express the short form of
CD21. The low frequency of isolation of CD21L cDNAs
from a tonsillar cDNA library reported earlier was probably
due to the fact that FDC are considerably less abundant in
tonsil than B cells (23). Thus, FDC and B cells exhibit a
cell type–specific splicing mechanism for CD21 expression.
CR2/CD21 has been shown to play key roles in B cell
activation and humoral immune responses. Monoclonal
Figure 2. Diagrams of CD21S and CD21L and their detection by
PCR assay. This figure is made according to Ahearn and Fearon (30).
Boxes represent the short consensus repeats (SCRs). 15 (CD21S) and 16
(CD21L) SCRs are grouped into four long homologous repeats indicated
by four different intensities of background. SCR10a is present in CD21L
but not in CD21S. The PCR was performed using: (a) a 59 primer start-
ing at bp 1,704 within the CD21S cDNA sequence, covering part of the
coding region of SCR10 (59 GGAGAGAGCACCATCCGTTG); and (b)
a 39 primer starting at position 2363 within the coding region of SCR11
(39 GGGCAGCGAGTCACAGGAGGAG). Accordingly, the predicted
PCR products derived from CD21S and CD21L mRNA should be 659
and 736 bp, respectively.
Figure 3. Isolation of highly purified FDC by FACSÒ sorting. (A) Low
density tonsillar cells were stained by anti–CD21-PE and anti–CD14-
FITC (detailed in Materials and Methods). FDCs were sorted according
to their CD2111CD141 phenotype. B cells and monocytes could be rec-
ognized as CD211CD142 and CD212CD141 cells, respectively. (B and
C) Giemsa staining of FACSÒ sorted FDC (3400 and 31,000).169 Liu et al. Brief Definitive Report
anti-CD21 and a recombinant CD21-Ig fusion protein
suppressed IgG responses to T cell–dependent antigens in
mice (24, 25). CD21-deficient mice exhibit deficiencies in
a B cell (B-1a) compartment, and in their ability to gener-
ate a T-dependent antibody response and GC reaction
(26). Remarkably, antigen (hen egg lysozyme; HEL) at-
tached to C3d (HEL-C3d) was 1,000–10,000-fold more
immunogenic than HEL alone when these antigens were
administered to mice (27). Several possible mechanisms
have been proposed for the biological functions of CR2/
CD21: (a) long-term retaining and presenting native anti-
gens in the form of immune complexes on FDC, (b) bind-
ing the B cell activation antigen CD23/FceRII (28), and (c)
serving as a co-receptor for B cell activation within the
TAPA-1/CD19/CD21 complex (29).
The differential expression of CD21L and CD21S, re-
spectively, on FDCs and B cells, may suggest their different
functions. For example, understanding the functional sig-
nificance of the additional SCR10a exon may provide a
clue for explaining the mechanisms by which FDCs retain
native antigen and costimulate GC B cells. The availability
of anti-CD21L antibodies specific for FDCs will facilitate
their purification after studies of their developmental path-
way and their functional characterization.
Figure 4. Detection of CD21S and CD21L mRNA by PCR among
CD2111CD141 FDCs, IgD1CD382 FM, and IgD2CD381 GC B cells.
The method for FDC isolation is detailed in Materials and Methods and
in Fig. 3. PCR primers used are indicated in the legend for Fig. 2. p7D6
cDNA was used as a positive control.
Figure 5. Partial sequence of the FDC-derived PCR product contains
the 177 bp that encode for the SCR10a. The FDC-derived PCR product
contains 836 bp. The sequence between positions 161 and 249 of FDC-
derived PCR product encodes for a part of SCR10 that can be found in
both CD21L and CD21S cDNA sequences. The 177 bp from position
249 to 426 can be found in CD21L and p7D6 cDNA sequences, but not
in the CD21S cDNA sequence (dash line). The sequence from position
426 to 480 encodes for part of SCR11 that can be found in both CD21L
and CD21S cDNA.
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